{
  "company": "LUPIN",
  "report_date": "August 9, 2022",
  "filename": "LUPIN_transcript_Aug_2022.pdf",
  "quarter": "Q1",
  "fiscal_year": "2023",
  "management_team": [
    "DR. KAMAL SHARMA - VICE CHAIRMAN, LUPIN LIMITED",
    "MS. VINITA GUPTA - CEO, LUPIN LIMITED",
    "MR. NILESH GUPTA - MANAGING DIRECTOR, LUPIN LIMITED",
    "MR. RAMESH SWAMINATHAN - EXECUTIVE DIRECTOR, GLOBAL",
    "KAMAL SHARMA - VICE CHAIRMAN, LUPIN LIMITED",
    "VINITA GUPTA - CEO, LUPIN LIMITED",
    "NILESH GUPTA - MANAGING DIRECTOR, LUPIN LIMITED",
    "RAMESH SWAMINATHAN - EXECUTIVE DIRECTOR, GLOBAL"
  ],
  "moderator": "Hello, and welcome to Lupin Limited Q1 FY23 Earnings Conference Call",
  "analysts": [],
  "qa_segments": [],
  "key_financial_metrics": {
    "sales_inr_crores": "3604",
    "growth_percentage": "9.9"
  },
  "business_highlights": [
    "launched one product Restasis, which was authorized generic \nfrom AbbVie in the Ô¨Årst quarter."
  ],
  "extraction_metadata": {
    "extraction_date": "2025-08-03T01:08:56.503907",
    "source_file": "data\\lupin\\LUPIN_transcript_Aug_2022.pdf",
    "text_length": 69455,
    "extraction_method": "PyMuPDF + Regex parsing + Filename analysis"
  }
}